HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claudin-4 immunohistochemistry is highly effective in distinguishing adenocarcinoma from malignant mesothelioma in effusion cytology.

AbstractBACKGROUND:
Adenocarcinoma can be challenging to distinguish from malignant mesothelioma in effusions, and this distinction often requires ancillary studies and clinical correlation. Immunohistochemistry for claudin-4, a tight-junction-associated protein, has recently been shown to distinguish adenocarcinoma from malignant mesothelioma, mostly in surgical specimens. Our aim was to validate and assess the immunoreactivity profile of claudin-4 in a large series of malignant effusions.
METHODS:
We evaluated 159 malignant effusions (84 adenocarcinomas and 75 malignant mesotheliomas). Claudin-4 immunohistochemistry was performed on cell-block paraffin sections and scored for staining intensity, staining pattern (cytoplasmic versus membranous), and percentage of positive tumor cells. Appropriate positive and negative controls were used throughout.
RESULTS:
All cases of mesothelioma were negative for claudin-4 (0 of 64). Eighty-three of 84 cases of adenocarcinoma were positive (99%); 1 case of serous carcinoma was negative. Most adenocarcinomas showed strong and diffuse membranous staining (71 of 84; 84%); 12 cases (14%) showed membranous staining of moderate intensity. The overall sensitivity for adenocarcinoma was 99% (83 of 84).
CONCLUSIONS:
Claudin-4 immunohistochemistry effectively distinguishes adenocarcinoma from malignant mesothelioma with high sensitivity and specificity in the evaluation of malignant effusions.
AuthorsVickie Y Jo, Edmund S Cibas, Geraldine S Pinkus
JournalCancer cytopathology (Cancer Cytopathol) Vol. 122 Issue 4 Pg. 299-306 (Apr 2014) ISSN: 1934-6638 [Electronic] United States
PMID24421209 (Publication Type: Comparative Study, Journal Article)
Copyright© 2014 American Cancer Society.
Chemical References
  • Biomarkers, Tumor
  • Claudin-4
Topics
  • Adenocarcinoma (chemistry, pathology)
  • Aged
  • Biomarkers, Tumor (analysis)
  • Biopsy, Needle
  • Claudin-4 (analysis)
  • Cytodiagnosis (methods)
  • Databases, Factual
  • Diagnosis, Differential
  • Female
  • Humans
  • Immunohistochemistry
  • Male
  • Mesothelioma (chemistry, pathology)
  • Middle Aged
  • Pleural Effusion, Malignant (chemistry, pathology)
  • Reproducibility of Results
  • Retrospective Studies
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: